BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32675782)

  • 21. Action and function of Faecalibacterium prausnitzii in health and disease.
    Ferreira-Halder CV; Faria AVS; Andrade SS
    Best Pract Res Clin Gastroenterol; 2017 Dec; 31(6):643-648. PubMed ID: 29566907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of gut dysbiosis in axial spondyloarthritis patients and improvement of experimental ankylosing spondyloarthritis by microbiome-derived butyrate with immune-modulating function.
    Min HK; Na HS; Jhun J; Lee SY; Choi SS; Park GE; Lee JS; Um IG; Lee SY; Seo H; Shin TS; Kim YK; Lee JJ; Kwok SK; Cho ML; Park SH
    Front Immunol; 2023; 14():1096565. PubMed ID: 37143677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. YYFZBJS ameliorates colorectal cancer progression in Apc
    Sui H; Zhang L; Gu K; Chai N; Ji Q; Zhou L; Wang Y; Ren J; Yang L; Zhang B; Hu J; Li Q
    Cell Commun Signal; 2020 Jul; 18(1):113. PubMed ID: 32677955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alter between gut bacteria and blood metabolites and the anti-tumor effects of Faecalibacterium prausnitzii in breast cancer.
    Ma J; Sun L; Liu Y; Ren H; Shen Y; Bi F; Zhang T; Wang X
    BMC Microbiol; 2020 Apr; 20(1):82. PubMed ID: 32272885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phages infecting Faecalibacterium prausnitzii belong to novel viral genera that help to decipher intestinal viromes.
    Cornuault JK; Petit MA; Mariadassou M; Benevides L; Moncaut E; Langella P; Sokol H; De Paepe M
    Microbiome; 2018 Apr; 6(1):65. PubMed ID: 29615108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer.
    Lopez-Siles M; Martinez-Medina M; Surís-Valls R; Aldeguer X; Sabat-Mir M; Duncan SH; Flint HJ; Garcia-Gil LJ
    Inflamm Bowel Dis; 2016 Jan; 22(1):28-41. PubMed ID: 26595550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Faecalibacterium prausnitzii-derived microbial anti-inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression.
    Xu J; Liang R; Zhang W; Tian K; Li J; Chen X; Yu T; Chen Q
    J Diabetes; 2020 Mar; 12(3):224-236. PubMed ID: 31503404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Faecalibacterium prausnitzii as a potential Antiatherosclerotic microbe.
    Yang HT; Jiang ZH; Yang Y; Wu TT; Zheng YY; Ma YT; Xie X
    Cell Commun Signal; 2024 Jan; 22(1):54. PubMed ID: 38243314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced Akkermansia muciniphila and Faecalibacterium prausnitzii levels in the gut microbiota of children with allergic asthma.
    Demirci M; Tokman HB; Uysal HK; Demiryas S; Karakullukcu A; Saribas S; Cokugras H; Kocazeybek BS
    Allergol Immunopathol (Madr); 2019; 47(4):365-371. PubMed ID: 30765132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative analysis of Faecalibacterium prausnitzii genomes shows a high level of genome plasticity and warrants separation into new species-level taxa.
    Fitzgerald CB; Shkoporov AN; Sutton TDS; Chaplin AV; Velayudhan V; Ross RP; Hill C
    BMC Genomics; 2018 Dec; 19(1):931. PubMed ID: 30547746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First steps towards combining faecal immunochemical testing with the gut microbiome in colorectal cancer screening.
    Grobbee EJ; Lam SY; Fuhler GM; Blakaj B; Konstantinov SR; Bruno MJ; Peppelenbosch MP; Kuipers EJ; Spaander MC
    United European Gastroenterol J; 2020 Apr; 8(3):293-302. PubMed ID: 32213018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Application of Computational Data Modeling to a Large-Scale Population Cohort Assists the Discovery of Inositol as a Strain-Specific Substrate for
    Dogra SK; Dardinier A; Mainardi F; Siegwald L; Bartova S; Le Roy C; Chou CJ
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986043
    [No Abstract]   [Full Text] [Related]  

  • 33. Human Gut Faecalibacterium prausnitzii Deploys a Highly Efficient Conserved System To Cross-Feed on β-Mannan-Derived Oligosaccharides.
    Lindstad LJ; Lo G; Leivers S; Lu Z; Michalak L; Pereira GV; Røhr ÅK; Martens EC; McKee LS; Louis P; Duncan SH; Westereng B; Pope PB; La Rosa SL
    mBio; 2021 Jun; 12(3):e0362820. PubMed ID: 34061597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A higher bacterial inward BCAA transport driven by Faecalibacterium prausnitzii is associated with lower serum levels of BCAA in early adolescents.
    Moran-Ramos S; Macias-Kauffer L; López-Contreras BE; Villamil-Ramírez H; Ocampo-Medina E; León-Mimila P; Del Rio-Navarro BE; Granados-Portillo O; Ibarra-Gonzalez I; Vela-Amieva M; Tovar AR; Torres N; Gomez-Perez FJ; Aguilar-Salinas C; Canizales-Quinteros S
    Mol Med; 2021 Sep; 27(1):108. PubMed ID: 34525937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gut microbiota: What impact on colorectal carcinogenesis and treatment?].
    Bruneau A; Baylatry MT; Joly AC; Sokol H
    Bull Cancer; 2018 Jan; 105(1):70-80. PubMed ID: 29217301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of preoperative gut microbiota on colorectal anastomotic leakage: preliminary results.
    Palmisano S; Campisciano G; Iacuzzo C; Bonadio L; Zucca A; Cosola D; Comar M; de Manzini N
    Updates Surg; 2020 Dec; 72(4):1013-1022. PubMed ID: 32062786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prophylactic
    Lapiere A; Geiger M; Robert V; Demarquay C; Auger S; Chadi S; Benadjaoud M; Fernandes G; Milliat F; Langella P; Benderitter M; Chatel JM; Sémont A
    Gut Microbes; 2020 Nov; 12(1):1-15. PubMed ID: 32985332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered gut microbiota of obesity subjects promotes colorectal carcinogenesis in mice.
    Kang X; Ng SK; Liu C; Lin Y; Zhou Y; Kwong TNY; Ni Y; Lam TYT; Wu WKK; Wei H; Sung JJY; Yu J; Wong SH
    EBioMedicine; 2023 Jul; 93():104670. PubMed ID: 37343363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics.
    Lopez-Siles M; Duncan SH; Garcia-Gil LJ; Martinez-Medina M
    ISME J; 2017 Apr; 11(4):841-852. PubMed ID: 28045459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age and fecal microbial strain-specific differences in patients with spondyloarthritis.
    Stoll ML; Weiss PF; Weiss JE; Nigrovic PA; Edelheit BS; Bridges SL; Danila MI; Spencer CH; Punaro MG; Schikler K; Reiff A; Kumar R; Cron RQ; Morrow CD; Lefkowitz EJ
    Arthritis Res Ther; 2018 Jan; 20(1):14. PubMed ID: 29382366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.